vs

Side-by-side financial comparison of CASTLE BIOSCIENCES INC (CSTL) and Smart Sand, Inc. (SND). Click either name above to swap in a different company.

Smart Sand, Inc. is the larger business by last-quarter revenue ($86.0M vs $83.7M, roughly 1.0× CASTLE BIOSCIENCES INC). Smart Sand, Inc. runs the higher net margin — 1.4% vs -17.4%, a 18.7% gap on every dollar of revenue. On growth, CASTLE BIOSCIENCES INC posted the faster year-over-year revenue change (-4.9% vs -5.8%). Over the past eight quarters, Smart Sand, Inc.'s revenue compounded faster (1.8% CAGR vs -1.9%).

Castle Biosciences Inc. is a commercial-stage diagnostic firm that develops and markets proprietary, clinically actionable tests for dermatological conditions such as melanoma and other skin cancers, plus rare diseases. It operates mainly in the U.S. healthcare market, focusing on segments with high unmet need for more accurate diagnostics to guide treatment choices.

Sand 9 is a fabless Micro-electromechanical system (MEMS) company based in Cambridge, Massachusetts. Sand 9 developed a piezoelectric MEMS resonator to serve as an alternative for quartz timing devices in applications such as smart phones, low-power wireless devices, and communications infrastructure equipment.

CSTL vs SND — Head-to-Head

Bigger by revenue
SND
SND
1.0× larger
SND
$86.0M
$83.7M
CSTL
Growing faster (revenue YoY)
CSTL
CSTL
+0.9% gap
CSTL
-4.9%
-5.8%
SND
Higher net margin
SND
SND
18.7% more per $
SND
1.4%
-17.4%
CSTL
Faster 2-yr revenue CAGR
SND
SND
Annualised
SND
1.8%
-1.9%
CSTL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CSTL
CSTL
SND
SND
Revenue
$83.7M
$86.0M
Net Profit
$-14.5M
$1.2M
Gross Margin
13.0%
Operating Margin
-3.1%
Net Margin
-17.4%
1.4%
Revenue YoY
-4.9%
-5.8%
Net Profit YoY
43.8%
-68.5%
EPS (diluted)
$-0.49
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSTL
CSTL
SND
SND
Q1 26
$83.7M
Q4 25
$87.0M
$86.0M
Q3 25
$83.0M
$92.8M
Q2 25
$86.2M
$85.8M
Q1 25
$88.0M
$65.6M
Q4 24
$86.3M
$91.4M
Q3 24
$85.8M
$63.2M
Q2 24
$87.0M
$73.8M
Net Profit
CSTL
CSTL
SND
SND
Q1 26
$-14.5M
Q4 25
$1.2M
Q3 25
$-501.0K
$3.0M
Q2 25
$4.5M
$21.4M
Q1 25
$-25.8M
$-24.2M
Q4 24
$3.7M
Q3 24
$2.3M
$-98.0K
Q2 24
$8.9M
$-430.0K
Gross Margin
CSTL
CSTL
SND
SND
Q1 26
Q4 25
79.0%
13.0%
Q3 25
77.5%
16.1%
Q2 25
79.5%
10.4%
Q1 25
81.4%
4.2%
Q4 24
81.3%
14.7%
Q3 24
81.8%
10.3%
Q2 24
83.3%
17.7%
Operating Margin
CSTL
CSTL
SND
SND
Q1 26
Q4 25
-4.4%
-3.1%
Q3 25
-8.2%
5.8%
Q2 25
-4.9%
-0.1%
Q1 25
-31.7%
-10.8%
Q4 24
4.7%
3.9%
Q3 24
5.9%
-7.8%
Q2 24
5.8%
4.8%
Net Margin
CSTL
CSTL
SND
SND
Q1 26
-17.4%
Q4 25
1.4%
Q3 25
-0.6%
3.2%
Q2 25
5.2%
24.9%
Q1 25
-29.4%
-37.0%
Q4 24
4.1%
Q3 24
2.6%
-0.2%
Q2 24
10.3%
-0.6%
EPS (diluted)
CSTL
CSTL
SND
SND
Q1 26
$-0.49
Q4 25
$-0.06
$0.03
Q3 25
$-0.02
$0.08
Q2 25
$0.15
$0.54
Q1 25
$-0.90
$-0.62
Q4 24
$0.32
$0.10
Q3 24
$0.08
$0.00
Q2 24
$0.31
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSTL
CSTL
SND
SND
Cash + ST InvestmentsLiquidity on hand
$63.8M
$22.6M
Total DebtLower is stronger
$10.1M
$15.0M
Stockholders' EquityBook value
$461.4M
$239.7M
Total Assets
$547.8M
$340.0M
Debt / EquityLower = less leverage
0.02×
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSTL
CSTL
SND
SND
Q1 26
$63.8M
Q4 25
$299.5M
$22.6M
Q3 25
$287.5M
$5.1M
Q2 25
$275.9M
$4.3M
Q1 25
$275.2M
$5.1M
Q4 24
$293.1M
$1.6M
Q3 24
$95.0M
$7.2M
Q2 24
$85.6M
$6.3M
Total Debt
CSTL
CSTL
SND
SND
Q1 26
$10.1M
Q4 25
$10.1M
$15.0M
Q3 25
$10.0M
$14.3M
Q2 25
$10.0M
$23.5M
Q1 25
$10.0M
$13.7M
Q4 24
$10.0M
$14.7M
Q3 24
$10.0M
$15.7M
Q2 24
$10.0M
$17.1M
Stockholders' Equity
CSTL
CSTL
SND
SND
Q1 26
$461.4M
Q4 25
$470.9M
$239.7M
Q3 25
$467.0M
$239.9M
Q2 25
$455.4M
$240.5M
Q1 25
$440.3M
$219.9M
Q4 24
$455.8M
$243.8M
Q3 24
$441.1M
$243.6M
Q2 24
$423.9M
$242.9M
Total Assets
CSTL
CSTL
SND
SND
Q1 26
$547.8M
Q4 25
$578.6M
$340.0M
Q3 25
$562.8M
$343.1M
Q2 25
$544.7M
$345.8M
Q1 25
$501.7M
$326.9M
Q4 24
$531.2M
$341.5M
Q3 24
$514.6M
$335.8M
Q2 24
$487.3M
$341.8M
Debt / Equity
CSTL
CSTL
SND
SND
Q1 26
0.02×
Q4 25
0.02×
0.06×
Q3 25
0.02×
0.06×
Q2 25
0.02×
0.10×
Q1 25
0.02×
0.06×
Q4 24
0.02×
0.06×
Q3 24
0.02×
0.06×
Q2 24
0.02×
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSTL
CSTL
SND
SND
Operating Cash FlowLast quarter
$-22.1M
$22.4M
Free Cash FlowOCF − Capex
$20.4M
FCF MarginFCF / Revenue
23.7%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
18.99×
TTM Free Cash FlowTrailing 4 quarters
$32.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSTL
CSTL
SND
SND
Q1 26
$-22.1M
Q4 25
$26.9M
$22.4M
Q3 25
$22.6M
$18.2M
Q2 25
$20.8M
$-5.1M
Q1 25
$-6.0M
$8.7M
Q4 24
$24.4M
$1.0M
Q3 24
$23.3M
$5.8M
Q2 24
$24.0M
$14.9M
Free Cash Flow
CSTL
CSTL
SND
SND
Q1 26
Q4 25
$19.7M
$20.4M
Q3 25
$7.8M
$14.8M
Q2 25
$11.6M
$-7.8M
Q1 25
$-10.8M
$5.2M
Q4 24
$16.8M
$-840.0K
Q3 24
$17.0M
$3.7M
Q2 24
$18.8M
$13.5M
FCF Margin
CSTL
CSTL
SND
SND
Q1 26
Q4 25
22.7%
23.7%
Q3 25
9.4%
15.9%
Q2 25
13.4%
-9.1%
Q1 25
-12.2%
7.9%
Q4 24
19.5%
-0.9%
Q3 24
19.8%
5.8%
Q2 24
21.6%
18.3%
Capex Intensity
CSTL
CSTL
SND
SND
Q1 26
Q4 25
8.3%
2.3%
Q3 25
17.9%
3.6%
Q2 25
10.7%
3.1%
Q1 25
5.4%
5.4%
Q4 24
8.8%
2.1%
Q3 24
7.4%
3.4%
Q2 24
6.0%
1.8%
Cash Conversion
CSTL
CSTL
SND
SND
Q1 26
Q4 25
18.99×
Q3 25
6.05×
Q2 25
4.60×
-0.24×
Q1 25
Q4 24
0.28×
Q3 24
10.29×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSTL
CSTL

Segment breakdown not available.

SND
SND

Sand$85.1M99%
Smart Systems Segment$980.0K1%

Related Comparisons